Trials / Conditions / Metastatic Malignant Neoplasm in the Liver

Metastatic Malignant Neoplasm in the Liver

21 registered clinical trials studyying Metastatic Malignant Neoplasm in the Liver — 8 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Local Liver Treatment for Multi-organ Colorectal Cancer Metastases NCT06449937	Anhui Provincial Hospital	N/A
Recruiting	Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreati NCT06016855	Vanderbilt-Ingram Cancer Center	Phase 4
Recruiting	Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Al NCT05863195	ECOG-ACRIN Cancer Research Group	Phase 3
Recruiting	Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunot NCT05039632	M.D. Anderson Cancer Center	Phase 1 / Phase 2
Recruiting	AU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver Metastatic Disease NCT05791448	University of Southern California	Phase 1
Recruiting	Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors NCT05040360	SWOG Cancer Research Network	Phase 2
Recruiting	Short Stitch Versus Traditional Suture for the Prevention of Incisional Hernia After Open Hepatectomy NCT04982653	M.D. Anderson Cancer Center	Phase 2
Active Not Recruiting	Transarterial Chemoembolization for the Treatment of Uveal Melanoma With Liver Metastases NCT04728633	Thomas Jefferson University	Phase 2
Recruiting	An Investigational Scan (Intravoxel Incoherent Motion Diffusion Weighted Imaging) for the Evaluation of Colore NCT04796818	M.D. Anderson Cancer Center	N/A
Active Not Recruiting	Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advance NCT03203525	M.D. Anderson Cancer Center	Phase 1
Terminated	Preoperative Immunotherapy (Pembrolizumab) for Patients With Colorectal Cancer and Resectable Hepatic Metastas NCT03844750	Chloe Atreya, MD, PhD	Phase 2
Active Not Recruiting	Pembrolizumab With Liver-Directed or Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors and Liver NCT03457948	Nicholas Fidelman, MD	Phase 2
Completed	Ipilimumab and Nivolumab With Immunoembolization in Treating Participants With Metastatic Uveal Melanoma in th NCT03472586	Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University	Phase 2
Unknown	Autologous CD8+ SLC45A2-Specific T Lymphocytes With Cyclophosphamide, Aldesleukin, and Ipilimumab in Treating NCT03068624	M.D. Anderson Cancer Center	Phase 1
Terminated	Liver Surgery and Chemotherapy in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be R NCT02738606	M.D. Anderson Cancer Center	Phase 2
Active Not Recruiting	Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis NCT02626312	M.D. Anderson Cancer Center	Phase 1
Completed	MRI-Guided Stereotactic Body Radiation Therapy in Treating Patients With Liver Metastases or Liver Cancer NCT02683200	Jonsson Comprehensive Cancer Center	EARLY_Phase 1
Completed	Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival NCT02364557	NRG Oncology	Phase 2 / Phase 3
Active Not Recruiting	Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions NCT02156739	M.D. Anderson Cancer Center	N/A
Completed	Trametinib in Treating Patients With Advanced Cancer With or Without Hepatic Dysfunction NCT02070549	National Cancer Institute (NCI)	Phase 1
Completed	4D PET/CT in Diagnosing Participants With Lung and Colorectal Cancer With Liver and Lung Metastasis NCT00862680	M.D. Anderson Cancer Center	—